Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Select Medical Holdings (SEM) Common Equity: 2009-2024

Historic Common Equity for Select Medical Holdings (SEM) over the last 16 years, with FY2024 value amounting to $2.0 billion.

  • Select Medical Holdings' Common Equity fell 1140.02% to $2.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.0 billion, marking a year-over-year decrease of 1140.02%. This contributed to the annual value of $2.0 billion for FY2024, which is 2837.79% up from last year.
  • Latest data reveals that Select Medical Holdings reported Common Equity of $2.0 billion as of FY2024, which was up 2837.79% from $1.5 billion recorded in FY2023.
  • In the past 5 years, Select Medical Holdings' Common Equity registered a high of $2.0 billion during FY2024, and its lowest value of $1.3 billion during FY2020.
  • Its 5-year average for Common Equity is $1.5 billion, with a median of $1.4 billion in 2022.
  • As far as peak fluctuations go, Select Medical Holdings' Common Equity soared by 3486.82% in 2020, and later soared by 231.25% in 2022.
  • Over the past 5 years, Select Medical Holdings' Common Equity (Annual) stood at $1.3 billion in 2020, then increased by 5.82% to $1.3 billion in 2021, then increased by 2.31% to $1.4 billion in 2022, then grew by 14.09% to $1.5 billion in 2023, then grew by 28.38% to $2.0 billion in 2024.
  • Its Common Equity was $2.0 billion in FY2024, compared to $1.5 billion in FY2023 and $1.4 billion in FY2022.